A detailed history of Schroder Investment Management Group transactions in Pfizer Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 7,166,487 shares of PFE stock, worth $208 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,166,487
Previous 6,165,723 16.23%
Holding current value
$208 Million
Previous $171 Million 17.19%
% of portfolio
0.23%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $25.3 Million - $29.6 Million
1,000,764 Added 16.23%
7,166,487 $201 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $13.3 Million - $15.3 Million
515,637 Added 9.13%
6,165,723 $171 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $18.3 Million - $23.7 Million
698,526 Added 14.11%
5,650,086 $163 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $42 Million - $49.1 Million
-1,308,159 Reduced 20.9%
4,951,560 $164 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $25.5 Million - $29.5 Million
-705,682 Reduced 10.13%
6,259,719 $230 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $117 Million - $152 Million
-2,963,147 Reduced 29.84%
6,965,401 $284 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $26.1 Million - $34 Million
-624,543 Reduced 5.92%
9,928,548 $509 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $57.2 Million - $69.8 Million
-1,307,392 Reduced 11.02%
10,553,091 $462 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $2.54 Million - $3.01 Million
54,484 Added 0.46%
11,860,483 $622 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $58.1 Million - $72 Million
1,269,340 Added 12.05%
11,805,999 $611 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $64.8 Million - $96 Million
1,567,089 Added 17.47%
10,536,659 $622 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $7.82 Million - $10 Million
-199,303 Reduced 2.17%
8,969,570 $386 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $2.72 Million - $3.08 Million
75,825 Added 0.83%
9,168,873 $359 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $71.6 Million - $80.7 Million
2,137,550 Added 30.73%
9,093,048 $329 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $55.5 Million - $70.5 Million
-1,656,761 Reduced 19.24%
6,955,498 $256 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $126 Million - $148 Million
3,963,298 Added 85.25%
8,612,259 $313 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $51.9 Million - $62.9 Million
-1,721,486 Reduced 27.02%
4,648,961 $152 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $71.2 Million - $102 Million
-2,634,947 Reduced 29.26%
6,370,447 $220 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $21.7 Million - $24.6 Million
-659,510 Reduced 6.82%
9,005,394 $353 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $16.6 Million - $21.5 Million
511,475 Added 5.59%
9,664,904 $350 Million
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $39.5 Million - $44.3 Million
-1,066,861 Reduced 10.44%
9,153,429 $397 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $11.4 Million - $12.6 Million
305,330 Added 3.08%
10,220,290 $434 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $35 Million - $39.9 Million
-910,578 Reduced 8.41%
9,914,960 $433 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $55.7 Million - $67.6 Million
-1,616,152 Reduced 12.99%
10,825,538 $477 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $8.56 Million - $9.13 Million
-259,571 Reduced 2.04%
12,441,690 $452 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $25.5 Million - $29.6 Million
-800,416 Reduced 5.93%
12,701,261 $451 Million
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $15.2 Million - $16.1 Million
456,811 Added 3.5%
13,501,677 $489 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $404 Million - $445 Million
13,044,866
13,044,866 $464 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.